| Biotechnology Industry | Healthcare Sector | Dr. Boliang Lou Ph.D. CEO | XSHE Exchange | CNE100003JW4 ISIN |
| CN Country | 21,370 Employees | - Last Dividend | 27 Jul 2023 Last Split | - IPO Date |
Pharmaron Beijing Co., Ltd. is a prominent entity in the life sciences industry, offering comprehensive drug research, development, and production services across the globe, including North America, Europe, Japan, Mainland China, and other international markets. Since its incorporation in 2004, the company has been headquartered in Beijing, the People's Republic of China. With a broad network of subsidiaries, Pharmaron Beijing Co., Ltd. is dedicated to supporting the life sciences sector through its extensive range of services tailored to meet the complex demands of drug research and development.
Pharmaron Beijing Co., Ltd. specializes in a wide array of services within the drug research and development spectrum, categorized into laboratory chemistry services, bioscience services, clinical development services, and more. Each category encompasses specific services designed to cater to various aspects of drug development processes.